Evidence map›Paper›PMID 33095421›Full record

ReviewMolecular imaging and biology2021

Implications of Biomolecular Corona for Molecular Imaging.

Morteza Mahmoudi, Anna Moore

Open access · greenAbstract readReview
In one paragraph

Review in Molecular imaging and biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Morteza MahmoudiPrecision Health Program, Michigan State University, East Lansing, MI, 48823, USA. mahmou22@msu.edu.
Anna MoorePrecision Health Program, Michigan State University, East Lansing, MI, 48823, USA. moorea57@msu.edu.ORCID 0000-0002-5218-7204
Michigan State University · US

Funding

Predictive Cancer Diagnostics and Therapy ResponseR01CA135650 · NCI · MICHIGAN STATE UNIVERSITY · PI MEDAROVA, ZDRAVKA O, MOORE, ANNA · 2008 to 2018
$4.6M
NCI NIH HHS R01 CA135650
6 · The paper itself

Abstract

The development of nanoparticle probes has opened up new possibilities for molecular imaging in the era of precision medicine. There are a wide range of nanoprobes that are being used for various modalities that have demonstrated promising potential in early detection, disease monitoring, and theranostics. However, the rate of successful clinical translation of the nanoprobes is very low and is affected by the lack of our understanding about nanoparticle interaction with biological fluids after systemic administration, thus representing an unmet clinical need. One of the poorly understood issues relates to the formation of biomolecular corona, a layer of biomolecules formed on the surface of nanoscale materials during their interactions with biological fluids. The biomolecular corona has several significant effects on the biodistribution of nanoprobes and their imaging ability by (i) reducing their targeting efficacy and (ii) affecting the intrinsic imaging properties (e.g., contrast capacity of magnetic nanoprobes). This review provides insights on the importance of considering biomolecular corona in the development of nanoprobes, which may enable their more efficient utilization for molecular imaging applications.

Indexed as

Molecular ImagingAnimalsContrast MediaDiseaseHumansNanoparticlesContrast MediaBiomolecular coronaMolecular imagingNanoparticleTargeting

Identifiers

PMID33095421
PMCPMC9578305
OpenAlexW3094540532

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.